|Mr. Lewis G. Gradon||MD, CEO & Executive Director||1.57M||N/A||1961|
|Ms. Lyndal York||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Andrew Somervell||Vice President of Products & Technology||N/A||N/A||N/A|
|Hayden Brown||Head of Capital Markets & Investor Relations||N/A||N/A||N/A|
|Raelene Leonard||Company Secretary & General Counsel||N/A||N/A||N/A|
|Daniel Adolph||Senior Communications & Investor Relations Manager||N/A||N/A||N/A|
|Mr. Paul N. Shearer B.Com.||Senior Vice President of Sales & Marketing||N/A||N/A||N/A|
|Ms. Nicola Talbot||Vice President of Human Resources||N/A||N/A||N/A|
|Mr. Jonathan Rhodes||Vice President of Supply Chain, Facilities & Sustainability||N/A||N/A||N/A|
|Mr. Marcus Driller||Vice President of Corporate||N/A||N/A||N/A|
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Fisher & Paykel Healthcare Corporation Limited’s ISS governance QualityScore as of 1 December 2023 is 6. The pillar scores are Audit: 5; Board: 5; Shareholder rights: 7; Compensation: 8.